Asia Pacific Life Science Analytics Market By Component (Services and Software), By Application (Sales & Marketing Support, Research and Development (R&D), Pharmacovigilance, Supply Chain Analytics and Regulatory Compliance), By End User (Pharmaceutical, Medical Devices, Biotechnology and Other End Users), By Delivery Mode (On-Premise and On-demand), By Type (Descriptive, Predictive, Reporting and Prescriptive), By Country, Industry Analysis and Forecast, 2020 - 2026

Analysis of Market Size & Trends

The Asia Pacific Life Science Analytics Market would witness market growth of 10.2% CAGR during the forecast period (2020-2026). Analytics platforms have not up till now reached the level of complete maturity necessary to act as a separate enterprise solution and these are still seen as modest assets within pharmaceutical companies. As the surge in the volume of data delivered through the new biological, clinical process, chemical, epidemiological, economic, and some other channels endures to grow, a novel era of analytics is evolving with more demand for analytics compute services. The analytics service supplier landscape external to the pharmaceutical companies is various and will keep growing till pharma itself catches up with some other industries.

Life science businesses are delicate. Precise risk assessment can be helpful to decrease the spread of epidemics, increase the expectancy of life, and avert mortalities among other aids. The life sciences industry is in a complex position. While on the one hand, it is dealing with challenges such as improving services, cost-reduction and being patient-centric.

The aids of analytics in life sciences are established in important areas like early detection of treatment as well as patterns of treatment, managing the intent of the patient to real results, and most prominently accomplishing the operational superiority to boost over the intellectual journey of patient centricity.

Based on Component, the market is segmented into Services and Software. Based on Application, the market is segmented into Sales & Marketing Support, Research and Development (R&D), Pharmacovigilance, Supply Chain Analytics and Regulatory Compliance. Based on End User, the market is segmented into Pharmaceutical, Medical Devices, Biotechnology and Other End Users. Based on Delivery Mode, the market is segmented into On-Premise and On-demand. Based on Type, the market is segmented into Descriptive, Predictive, Reporting and Prescriptive. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: Life Science Analytics Market in Asia Pacific is expected to register a CAGR of 10.2% during the forecast period (2020-2026)

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Oracle Corporation, IBM Corporation, Microsoft Corporation, Accenture PLC, Cognizant Technology Solutions Corporation, Infosys Limited, IQVIA Holdings, Inc., AllScripts Healthcare Solutions, Inc., Cerner Corporation and SAS Institute, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Component

• Services
• Software

By Application

• Sales & Marketing Support
• Research and Development (R&D)
• Pharmacovigilance
• Supply Chain Analytics
• Regulatory Compliance

By End User

• Pharmaceutical
• Medical Devices
• Biotechnology
• Other End Users

By Delivery Mode

• On-Premise
• On-demand

By Type

• Descriptive
• Predictive
• Reporting
• Prescriptive

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Companies Profiled

• Oracle Corporation
• IBM Corporation
• Microsoft Corporation
• Accenture PLC
• Cognizant Technology Solutions Corporation
• Infosys Limited
• IQVIA Holdings, Inc.
• AllScripts Healthcare Solutions, Inc.
• Cerner Corporation
• SAS Institute, Inc.